**This message is sent on behalf of Yves Beauchamp, Vice-Principal (Administration and Finance) and Rose Goldstein, Vice-Principal (Research and Innovation)
Dear Colleagues,
**This message is sent on behalf of Yves Beauchamp, Vice-Principal (Administration and Finance) and Rose Goldstein, Vice-Principal (Research and Innovation)
Dear Colleagues,
The Montreal Neurological Institute and Hospital (The Neuro) is home to Canada鈥檚 first multiple sclerosis (MS) clinic, and MS research and treatment has been a major focus at The Neuro for many years. The MS clinic employs a highly specialized staff who have access to the latest research data and methods of treatment. It is a clinic where innovation and progress are paramount.
Brain diseases and disorders are the leading cause of disability, directly affecting one in three Canadians as well as millions of family members, friends, colleagues and caregivers. The Government of Canada recognizes the significant impact on the health of Canadians, and supports Canadian research on the brain and related diseases and disorders
The ability to remember sounds, and manipulate them in our minds, is incredibly important to our daily lives 鈥 without it we would not be able to understand a sentence, or do simple arithmetic. New research is shedding light on how sound memory works in the brain, and is even demonstrating a means to improve it.
March 26 is Purple Day for Epilepsy, a day to support epilepsy awareness worldwide
The Neuro has been a world leader in epilepsy treatment and research for more than 60 years. Indeed, the 鈥淢ontreal Procedure鈥 developed by The Neuro鈥檚 founder, Dr. Wilder Penfield, and his colleagues has become the standard operating procedure for the surgical treatment of epilepsy. The Neuro was also a pioneering institute in exploiting electroencephalography (EEG) and magnetic resonance imaging (MRI) to study and treat epilepsy.
In an article published in Nature on Feb. 15, 2017, researchers, including principal investigators from the Montreal Neurological Institute鈥檚 McConnell Brain Imaging Centre (BIC), used magnetic resonance imaging (MRI) to predict the development of autism in babies.
Montreal, Quebec and Vancouver, British Columbia 鈥 Working together to accelerate research into neurological diseases, three leading players in Canada鈥檚 health sciences sector are joining forces in a unique multi-million dollar partnership to create a novel drug development platform that will help advance new therapeutics for some of the most debilitating conditions such as amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig鈥檚 disease, and Parkinson鈥檚 disease.
A foray into plant biology led one researcher to discover that a natural molecule can repair axons, the thread-like projections that carry electrical signals between cells. Axonal damage is the major culprit underlying disability in conditions such as spinal cord injury and stroke.
Research and clinical care complement each other at The Neuro
February 28th was Rare Diseases Day, an opportunity to recognize a class of disease that is often overlooked. In the past five years, the Montreal Neurological Institute and Hospital (The Neuro) has made the study and treatment of rare diseases a major priority, hiring new specialists and support staff and coordinating activity under a new research group.
In September 2016, the federal government made an unparalleled investment in research and innovation, announcing $84 million in funding over seven years for 捆绑SM社区鈥檚 Healthy Brains for Healthy Lives initiative, as part of the Canada First Research Excellence Fund (CFREF) program. Following this announcement, a committee for the selection of the HBHL Managing Director engaged in an extensive search and interview process. The Chair of the Selection Committee, Vice-Principal Rosie Goldstein, is now pleased to announce the appointment of Dr.
In September 2016, the federal government made an unparalleled investment in research and innovation, announcing $84 million in funding over seven years for 捆绑SM社区鈥檚 Healthy Brains for Healthy Lives initiative, as part of the Canada First Research Excellence Fund (CFREF) program. Following this announcement, a committee for the selection of the HBHL Managing Director engaged in an extensive search and interview process. The Chair of the Selection Committee, Vice-Principal Rosie Goldstein, is now pleased to announce the appointment of Dr.
CQDM and Brain Canada join forces again in the funding of two new research projects to address unmet needs in brain research
CQDM and Brain Canada are proud to announce the funding of two new multi-disciplinary and multi-institutional research projects under the second edition of their Focus on Brain strategic initiative. The partners will award a total of $3M to two research teams to develop cutting-edge tools, technologies and platforms designed to accelerate the discovery of new drugs for brain and nervous system disorders.
An all-star lineup of experts in the fields of sports and neurology will share a stage on Jan. 27 to discuss concussions, a serious injury that has only recently been getting the attention it deserves.
The聽85th聽Congr猫s annuel de l鈥橝ssociation francophone pour le savoir聽(Acfas) may be five months away, but 捆绑SM社区 is already busy getting ready to host what is the largest French-language interdisciplinary conference in the world.
Researchers urged not to miss Nov. 1 deadline for colloquia proposals.